BAFF-var as a Biomarker of Response to B-depletive Treatment in Systemic Lupus Erythematosus and Rheumatoid Arthritis

NCT05659407 · clinicaltrials.gov ↗

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Systemic Lupus Erythematosus
Rheumatoid Arthritis
BLyS Polymorphism

Interventions

DRUG: Belimumab in SLE patients / Rituximab in RA patients

Sponsor

University of Cagliari

Collaborators

[object Object]